The patent office in India rejects Pfizer's petition for a patent on an arthritis drug, tofacitinib, re-affirming their rejection of the same drug in 2011. The drug is a chemical reformulation of the active compound in the medicine and thus the Indian Patent Office says that the company would have to establish that the compound for which it is seeking a patent is therapeutically more effective than the active compound. (Reuters)In response to the $13.6 billion cash-and-stock offer by the Marriott International to purchase Starwood Hotels and Resorts Worldwide, Anbang Insurance Group raises its bidding offer to $14 billion. (AP) (Reuters) (UPI) (The Washington Post)